Brenig Therapeutics announced the initiation of the first-in-human clinical trial for BT-267, a best-in-class LRRK2 inhibitor developed as a potential disease-modifying treatment for idiopathic...
Norton Neuroscience Institute is the first and only facility in Kentucky to offer MRI-guided high-frequency focused ultrasound for essential tremor and tremor-dominant Parkinson’s disease. This life-changing...
Dyno Therapeutics, Inc, a techbio company pioneering applications of artificial intelligence to engineer AAV capsids that can expand the potential of genetic medicine, announced...
Cala, the bioelectronic medicine leader setting a new standard of care for chronic disease, announced meeting the primary endpoint on an interim analysis of...
Brain research and advocacy non-profit Cohen Veterans Bioscience (CVB) announces the publication of results from its data sciences research program. As part of the drive toward...
